openPR Logo
Press release

Complex Regional Pain Syndrome (CRPS) Therapeutics Market Future Opportunities 2020

03-01-2018 12:23 PM CET | Health & Medicine

Press release from: Transparency Market Research

Complex Regional Pain Syndrome (CRPS) Therapeutics Market

Complex regional pain syndrome is a debilitating chronic pain condition causing intense pain particularly in the arms, hands, legs, or feet. This syndrome is characterized by pain, swelling, vasomotor instability, limited range of motion, skin color changes and patchy bone demineralization. CRPS is often regarded to be caused as a result of malfunction of failure of peripheral and central nervous system and therefore also sometimes referred as reflex sympathetic dystrophy syndrome. Complex regional pain syndrome (CRPS) is classified into two similar forms termed as CRPS type 1 (Reflex Sympathetic Dystrophy or RSD) and CRPS type 2 (Causalgia). The former type mentioned has been used for individuals with confirmed nerve injuries while the latter type is used to refer patients without any confirmed nerve injury.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2500

It is noteworthy to mention that the disease prevalence is very low and therefore classified as an orphan disease. Furthermore, since the sympathetic nervous systems affect several systems simultaneously, development of drugs for treating complex regional pain syndrome had been painstaking task for the researchers. However, the expanding knowledge base in neurology and medicine provides unique and underserved market opportunity for drugs and products in complex regional pain syndrome disease.

Presently there is no cure for the disease but drug therapies help in alleviating the pain associated with the disease as wells reduce the progression of the disease. Multimodal therapy is prescribed for the treatment of chronic regional pain syndrome which includes psychotherapy, rehabilitation therapy and drug therapy. Drug therapy for CRPS includes non-steroidal anti-inflammatory drugs (aspirin, ibuprofen, and naproxen) used to treat moderate pain while corticosteroids such as prednisolone and methylprednisolone are prescribed to treat inflammation and edema in the early stages of CRPS. Drugs effective in neuropathic pain are also administered to patients with CRPS.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2500

These drugs include gabapentin, amitryptiline, nortryptiline and duloxetine. Other therapeutic drugs useful in complex regional pain syndrome (CRPS) include oxytocins, morphine, hydrocodone, vicodin, N-methyl-D-aspartate (NMDA) receptor antagonists (dextromethorphan) and botulinum toxin injections. Several emerging therapies are being evaluated for the treating CRPS which include intravenous immunoglobulin (IVIG), ketamine and hyperbaric oxygen therapy.

Administering of calcitonin subcutaneously or by intra-nasal spray over 3-4 weeks is being studied for benefits against CRPS disease. Similarly, the experimental therapies such as motor cortex and deep brain stimulation are also being studied which may provide breakthrough improvement in the CRPS treatment therapy. Recently, Neridronate (amino bisphosphonate) has been studied for its effects on CRPS and has demonstrated significant reduction in symptoms. This molecule has been awarded with orphan designation status by the FDA but has not yet approved. We can expect that this drug molecule may enter the market upon successful completion of clinical trials.

The National Institutes of Health (NIH) supports research on complex regional pain syndrome through funding for the National Institute of Neurogical Disorders and Stroke (NINDS). Some of the companies in the global complex regional pain syndrome (CRPS) therapeutics market which are engaged in the research and development of pain management products for treating CRPS disease include Abiogen Pharma S.p.A., AlgoRx Pharmaceuticals, Inc., Amgen Inc.,Bayer AG, Celgene Corporation, Cell Targeting Technologies, CeNeS Pharmaceuticals plc, Danish Pain Research Center, Eli Lilly & Co., Endo Pharmaceuticals, Forest Laboratories Inc., GlaxoSmithKline plc, Grünenthal GmbH Johnson & Johnson, Justus Liebig University Giessen, King Pharmaceuticals Inc., Lee's Pharmaceutical Holdings Limited, National Institute of Nursing Research (NINR), NeurogesX, Inc., Pfizer, Inc., Stichting Achmea Slachtofferhulp Samenleving, and University of California.

Obtain Report Details @ https://www.transparencymarketresearch.com/complex-regional-pain-syndrome-therapeutics.html

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Complex Regional Pain Syndrome (CRPS) Therapeutics Market Future Opportunities 2020 here

News-ID: 962532 • Views: 174

More Releases from Transparency Market Research

Utility-Scale Energy Storage Technologies Market Advanced Technology and New Inn …
Global Utility-Scale Energy Storage Technologies Market: Overview The increasing demand for energy is accelerating the deployment of utility-scale energy storage technologies around the world. The benefits offered by these technologies in terms of increasing the efficiency of energy storage are projected to help the market grow in the near future. In addition, the rising demand for reducing the carbon footprint is expected to propel the growth of the global utility-scale energy
Corporate Travel Security Market to Witness an Outstanding Growth during 2019 …
Corporate Travel Security Market: Introduction Transparency Market Research delivers key insights on the corporate travel security market. In terms of revenue, the corporate travel security market is estimated to expand at a CAGR of ~4% during the forecast period, owing to numerous factors regarding which TMR offers thorough insights and forecasts in the corporate travel security market report. In the report, TMR predicts that the corporate travel security market would be
Distribution Automation Market Segmentation Application, Technology and Market A …
Global Distribution Automation Market: Overview Reaching a significant market worth by 2027, the global distribution automation market is set to chart a notable CAGR (Compound Annual Growth Rate) owing to an increase in generation of renewable energy, and a rising demand for energy efficiency. It is worth pointing out here that developing countries such as India are witnessing an increase in distributed energy generation and that is leading a plethora of untapped
Insulated Packaging Market Entry Strategies, Countermeasures of Economic Impact …
Insulated Packaging Market: Introduction Insulation material is defined as a material or combination of different materials having low thermal conductivity to resist the flow of heat. Thermal abuse is the major concern faced during the transportation of temperature sensible products; hence, most of the major industries such as food and beverages, pharmaceutical, healthcare, chemicals, cosmetics, etc., depend heavily on insulated materials for packaging. Products from these industries may be subjected to

All 5 Releases


More Releases for CRPS

Complex Regional Pain Syndrome (CRPS) Therapeutics Clinical Trials & Results | A …
Complex regional pain syndrome (CRPS) is a type of chronic pain that affects one limb of the body (hand, leg, arm, or foot). The condition generally arises due to severe injuries or malfunctioning of central and peripheral nervous systems. Download the sample report @ https://www.pharmaproff.com/request-sample/1096 CRPS is categorized into two main types: CRPS-I and CRPS-II. CRPS-I is associated with unconfirmed nerve injury; whereas, CRPS-II is associated with confirmed nerve injury. CRPS
Complex Regional Pain Syndrome Market By Therapy Type, By Route of Administratio …
Complex Regional Pain Syndrome (CRPS) is a chronic condition that causes severe pain in legs, arms, feet, and hands or may involve the entire body. CRPS is commonly of two types, with similar symptoms and treatment. If Complex Regional Pain syndrome occurs after an injury without any nerve damage, it is known as Type I CRPS (also known as reflex sympathetic dystrophy). Type II CRPS occurs after a specific nerve
Complex Regional Pain Syndrome (CRPS) Therapeutics Market to Reflect Impressive …
Complex regional pain syndrome is a debilitating chronic pain condition causing intense pain particularly in the arms, hands, legs, or feet. This syndrome is characterized by pain, swelling, vasomotor instability, limited range of motion, skin color changes and patchy bone demineralization. CRPS is often regarded to be caused as a result of malfunction of failure of peripheral and central nervous system and therefore also sometimes referred as reflex sympathetic dystrophy
Global Complex Regional Pain Syndrome (CRPS) Therapeutics Market to Register Sub …
Complex regional pain syndrome is a debilitating chronic pain condition causing intense pain particularly in the arms, hands, legs, or feet. This syndrome is characterized by pain, swelling, vasomotor instability, limited range of motion, skin color changes and patchy bone demineralization. CRPS is often regarded to be caused as a result of malfunction of failure of peripheral and central nervous system and therefore also sometimes referred as reflex sympathetic dystrophy
Complex Regional Pain Syndrome (CRPS) Therapeutics Market - Competitive Dynamics …
Complex regional pain syndrome is a debilitating chronic pain condition causing intense pain particularly in the arms, hands, legs, or feet. This syndrome is characterized by pain, swelling, vasomotor instability, limited range of motion, skin color changes and patchy bone demineralization. CRPS is often regarded to be caused as a result of malfunction of failure of peripheral and central nervous system and therefore also sometimes referred as reflex sympathetic dystrophy
Complex Regional Pain Syndrome (CRPS) Therapeutics Market - Global Industry Anal …
Albany, NY, 20 JAN : Presently there is no cure for the disease but drug therapies help in alleviating the pain associated with the disease as wells reduce the progression of the disease. Multimodal therapy is prescribed for the treatment of chronic regional pain syndrome which includes psychotherapy, rehabilitation therapy and drug therapy. Drug therapy for CRPS includes non-steroidal anti-inflammatory drugs (aspirin, ibuprofen, and naproxen) used to treat moderate pain